[Nphe1]Nociceptin (1-13) NH2 (TFA)

[Nphe1]Nociceptin (1-13) NH2, a novel nociceptin/orphanin FQ (NC) endogenous ligand, is a selective and competitive ociceptin receptor antagonist without any residual agonist activity. [Nphe1]nociceptin (1-13) NH2 binds selectively to recombinant nociceptin receptors (pKi=8.4) and antagonizes the inhibitory effects of nociceptin on cyclic AMP accumulation in CHO cells (pA2=6.0) . [Nphe1]Nociceptin (1-13) NH2 has the potential to act as an analgesic agent[1].

Product Specifications

UNSPSC

12352209

Target

Opioid Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/nphe1-nociceptin-1-13-nh2-tfa.html

Solubility

10 mM in DMSO

Smiles

OC(C(F)(F)F)=O.NCCCC[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](C)NC([C@H](CO)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC([C@H](C)NC(CNC([C@H]([C@H](O)C)NC([C@@H](NC(CNC(CNC(CNCC1=CC=CC=C1)=O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C63H101F3N22O17

Molecular Weight

1495.61

References & Citations

[1]Y Hashimoto, et al. Antagonistic effects of [Nphe1]nociceptin (1-13) NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor|[2]G Calo', et al. Characterization of [Nphe (1) ]nociceptin (1-13) NH (2), a new selective nociceptin receptor antagonist. Br J Pharmacol. 2000 Mar;129 (6) :1183-93.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-32661 0.1 mL

Rabbit Polyclonal Homez Antibody

View Details

MBS1419108-01 0.5 mg (E-Coli)

Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial

View Details

MBS1419108-02 0.05 mg (Baculovirus)

Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial

View Details

MBS1419108-03 0.5 mg (Yeast)

Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial

View Details

MBS1419108-04 0.05 mg (Mammalian-Cell)

Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial

View Details

MBS1419108-05 1 mg (E-Coli)

Recombinant Human V-set and immunoglobulin domain-containing protein 10-like (VSIG10L), partial

View Details